Dean Follmann

机构：National Institutes of Health, National Institute of Allergy and Infectious Diseases · ORCID：0000-0003-4073-0393

发表论文 284 篇 · 总被引 17578 次 · h-index 56

代表论文

• Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases (2024 · Nature Communications · 被引 37)
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial (2024 · Nature Communications · 被引 21)
• SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir (2024 · The Journal of Infectious Diseases · 被引 13)
• Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost (2025 · Nature Communications · 被引 9)
• Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial (2024 · Nature Communications · 被引 9)
• Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial (2024 · Open Forum Infectious Diseases · 被引 8)